UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacology of the short QT syndrome N588K‐hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

British journal of pharmacology, 2008-11, Vol.155 (6), p.957-966

2008

Volltextzugriff (PDF)

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin

Biochemical pharmacology, 2007-08, Vol.74 (3), p.425-437

2007

Volltextzugriff (PDF)

Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform

Biochemical and biophysical research communications, 2011-02, Vol.405 (2), p.222-227

2011

Volltextzugriff (PDF)

hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome

Biochemical and biophysical research communications, 2009-08, Vol.386 (1), p.111-117

2009

Volltextzugriff (PDF)

Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009-03, Vol.60 (1), p.23

2009

Volltextzugriff (PDF)

Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2010-04, Vol.61 (2), p.123

2010

Volltextzugriff (PDF)

10 Voltage-dependent affinity of some compounds that inhibit hERG: rapid dissociation and reassociation?

Heart (British Cardiac Society), 2011-01, Vol.97 (1), p.e3-e3

2011

Volltextzugriff (PDF)

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C

Biochemical and biophysical research communications, 2005-08, Vol.334 (2), p.441

2005

Volltextzugriff (PDF)

Pharmacology of the short QT syndrome N588KhERG K+ channel mutation : differential impact on selected class I and class III antiarrhythmic drugs

British journal of pharmacology, 2008, Vol.155 (6), p.957-966

2008

Volltextzugriff (PDF)

The N588K-HERG K super(+) channel mutation in the 'short QT syndrome': Mechanism of gain-in-function determined at 37 super(o)C

Biochemical and biophysical research communications, 2005-08, Vol.334 (2), p.441-449

2005

Volltextzugriff (PDF)

Role of catalase in the smooth muscle relaxant actions of sodium azide and cyanamide

European journal of pharmacology, 2002-01, Vol.435 (1), p.93-101

2002

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Animals
(8)
Life Sciences & Biomedicine
(8)
Cho Cells
(5)
Cricetinae
(5)
Cricetulus
(5)
Erg1 Potassium Channel
(5)
Humans
(5)
Electrophysiology
(4)
Herg
(4)
Mutation
(4)
Patch-Clamp Techniques
(4)
Qt Interval
(4)
Biochemistry & Molecular Biology
(3)
Biological And Medical Sciences
(3)
Biophysics
(3)
Ether-A-Go-Go Potassium Channels - Genetics
(3)
Medical Sciences
(3)
Pharmacology & Pharmacy
(3)
Pharmacology. Drug Treatments
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacology of the short QT syndrome N588K‐hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin

Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform

hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome

Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study

Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation

10 Voltage-dependent affinity of some compounds that inhibit hERG: rapid dissociation and reassociation?

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C

Pharmacology of the short QT syndrome N588KhERG K+ channel mutation : differential impact on selected class I and class III antiarrhythmic drugs

The N588K-HERG K super(+) channel mutation in the 'short QT syndrome': Mechanism of gain-in-function determined at 37 super(o)C

Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation

Role of catalase in the smooth muscle relaxant actions of sodium azide and cyanamide

Suchergebnisse filtern